Cairo University

🇪🇬Egypt

Country: 🇪🇬Egypt

Ownership: Private

Established: 1908-01-01

Employees: 10K

Market Cap: -

Website: http://www.cu.edu.eg

Clinical Trials

Tramadol Versus Celecoxib for Reducing Pain During Office Hysteroscopy in Post Menopausal Women

Phase 3

Conditions: Hysteroscopy

Interventions: Drug: Celecoxib
Drug: Placebo 1
Drug: Tramadol
Drug: Placebo 2

First Posted Date: 2016-04-13

Last Posted Date: 2016-07-06

Lead Sponsor: Cairo University

Target Recruit Count: 210

Registration Number: NCT02736019

Locations: 🇪🇬
Cairo University Hospitals, Cairo, Egypt

Dehydroepiandrosterone Versus Growth Hormone in Women Undergoing ICSI With Expected Poor Ovarian Response

Phase 3

Conditions: Subfertility

Interventions: Drug: Growth Hormone-Releasing Hormone
Drug: DHEA
Drug: Placebo 2
Drug: Placebo 1

First Posted Date: 2016-04-13

Last Posted Date: 2016-07-06

Lead Sponsor: Cairo University

Target Recruit Count: 210

Registration Number: NCT02736591

Locations: 🇪🇬
Cairo University Hospitals, Cairo, Egypt
🇪🇬
Dar AlTeb subfertility centre, Cairo, Egypt

Tramadol Versus Celecoxib for Reducing Pain During Operative Office Hysteroscopy

Phase 3

Conditions: Hysteroscopy

Interventions: Drug: Celecoxib
Drug: Tramadol
Drug: Placebo 1
Drug: Placebo 2

First Posted Date: 2016-04-13

Last Posted Date: 2016-07-06

Lead Sponsor: Cairo University

Target Recruit Count: 210

Registration Number: NCT02736071

Locations: 🇪🇬
Cairo University Hospitals, Cairo, Egypt

Cryopreserved-thawed Embryo Transfer With or Without Gonadotropin Releasing Hormone Agonist

Phase 3

Completed

Conditions: Infertility

Interventions: Procedure: Embryo transfer
Procedure: Serum Estradiol and Progesterone levels
Drug: GnRH agonist
Drug: External Estradiol
Drug: Progesterone

First Posted Date: 2016-04-13

Last Posted Date: 2018-05-17

Lead Sponsor: Cairo University

Target Recruit Count: 310

Registration Number: NCT02736032

Locations: 🇪🇬
Nile IVF center, Giza, Egypt
🇪🇬
IVF centre, Obstetrics and Gynaecology Department, Cairo University Hospitals (Kasr EL Aini), Cairo, Egypt
🇪🇬
Kamal Shaeer center of infertility, Giza, Egypt

Surgical Classification of Abnormal Placentation

Not Applicable

Conditions: Adherent Placenta

Interventions: Device: Trans- abdominal sonography
Device: Trans-vaginal sonography
Procedure: post-operative pathological specimen examination

First Posted Date: 2016-04-13

Last Posted Date: 2016-06-01

Lead Sponsor: Cairo University

Target Recruit Count: 100

Registration Number: NCT02736058

Locations: 🇪🇬
Kasr el aini hospital, Cairo, Egypt

Internal Iliac Artery Ligation and Abnormally Invasive Placenta

Not Applicable

Completed

Conditions: Placenta Percreta

Interventions: Procedure: internal iliac artery ligation
Procedure: Cesarean Hysterectomy

First Posted Date: 2016-04-05

Last Posted Date: 2017-04-18

Lead Sponsor: Cairo University

Target Recruit Count: 50

Registration Number: NCT02728232

Locations: 🇪🇬
Kasr el aini hospital, Cairo, Egypt

Effect Of Dexmedetomidine On Sublingual Microcirculation In Patients Undergoing On Pump CABG Surgery

Phase 4

Conditions: Sublingual Microcirculation

Interventions: Drug: Placebo for Dexmedetomidine normal saline infusion
Drug: Dexmedetomidine
Drug: Propofol infusion

First Posted Date: 2016-03-21

Last Posted Date: 2018-01-24

Lead Sponsor: Cairo University

Target Recruit Count: 70

Registration Number: NCT02714725

Locations: 🇪🇬
Kasr Al-Ainy hospitals , Faculty of medicine , Cairo university, Cairo, Egypt

Efficacy of Different Perioperative Statin Regimens on the Protection Against Post Coronary Artery Bypass Grafting Major Adverse Cardio-cerebral Events

Phase 4

Completed

Conditions: Coronary Artery Bypass Grafting

Interventions: Drug: Atorvastatin

First Posted Date: 2016-03-11

Last Posted Date: 2016-03-14

Lead Sponsor: Cairo University

Target Recruit Count: 94

Registration Number: NCT02706860

Effect of Hydrocortisone on Improving Outcome of Pneumatic Reduction of Infantile Intussusception

Not Applicable

Recruiting

Conditions: Intussusception

Interventions: Drug: Saline
Drug: Hydrocortisone

First Posted Date: 2016-02-25

Last Posted Date: 2024-08-27

Lead Sponsor: Cairo University

Target Recruit Count: 80

Registration Number: NCT02691858

Locations: 🇪🇬
Cairo University Pediatric Hospital, Cairo, Egypt

Response Modifier (Arabinoxylan Rice Bran/MGN-3/Biobran) With Interferon-Alpha for HCV

Phase 2

Completed

Conditions: Hepatitis C, Chronic

Interventions: Dietary Supplement: Biobran
Drug: pegylated IFN
Drug: Ribavirin

First Posted Date: 2016-02-24

Last Posted Date: 2016-02-24

Lead Sponsor: Cairo University

Target Recruit Count: 37

Registration Number: NCT02690103

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy